Skip to main content
$321.45 $0.43 (0.1%)

04:00 PM EST on 01/27/23

Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 4 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Current Price $321.45 Mkt Cap $82.4B
Open $321.00 P/E Ratio 25.09
Prev. Close $321.45 Div. (Yield) $0.00 (0.0%)
Daily Range $319.58 - $323.67 Volume 1,288,678
52-Wk Range $225.28 - $324.75 Avg. Daily Vol. 1,462,204

Caps

How do you think NASDAQ:VRTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

881 Outperform
71 Underperform
 

All-Star Players

191 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VRTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cnd79 (28.15)
Submitted October 07, 2022

RoE: 30.02DEBT TO EQUITY: 8.2Revenue growth past 5 yr: 34.79%FREE CASH FLOW GROWTH PAST 5 YR: 117.03

SCOTTRHUETTLCPA (38.87)
Submitted July 22, 2016

9/26/14 DOWN TO UP = <30.04> 7/19/16 = UP TO DOWN

Recent Community Commentary

Read the most recent pitches from players about VRTX.

Recs

1
Member Avatar cnd79 (28.15) Submitted: 10/7/2022 1:30:25 PM : Outperform Start Price: $297.88 NASDAQ:VRTX Score: -3.58

RoE: 30.02
DEBT TO EQUITY: 8.2
Revenue growth past 5 yr: 34.79%
FREE CASH FLOW GROWTH PAST 5 YR: 117.03

Recs

1
Member Avatar 1russianguy (79.20) Submitted: 6/29/2022 3:29:34 PM : Outperform Start Price: $217.44 NASDAQ:VRTX Score: +30.62

Can thrive during recession.

Recs

1
Member Avatar TMFjimhalley (21.46) Submitted: 6/7/2022 10:01:04 PM : Outperform Start Price: $272.20 NASDAQ:VRTX Score: +20.26

The company has six therapies in late-stage trials and is already profitable because of its cystic fibrosis drugs.

Leaderboard

Find the members with the highest scoring picks in VRTX.

Score Leader

bugeyebear

bugeyebear (50.01) Score: +1,879.89

The Score Leader is the player with the highest score across all their picks in VRTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
bugeyebear 50.01 3/17/2008 Outperform 3Y $14.60 +2,112.47% +232.58% +1,879.89 0 Comment
lostontheprairie 67.74 3/12/2008 Outperform 5Y $14.99 +2,054.90% +219.84% +1,835.06 0 Comment
Kudude 68.14 3/12/2008 Outperform 5Y $14.99 +2,054.90% +219.84% +1,835.06 0 Comment
Salilp 71.39 3/17/2008 Outperform 5Y $15.07 +2,043.46% +235.42% +1,808.05 0 Comment
davidmouw2 < 20 3/14/2008 Outperform NS $15.43 +1,993.45% +219.75% +1,773.71 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. snazzysnazz 72.26 3/13/2008 Outperform 5Y $15.49 +1,985.35% +227.56% +1,757.78 0 Comment
NovaMechanika 28.46 3/20/2008 Outperform 3Y $15.55 +1,977.30% +224.85% +1,752.45 2 Comments
stnewbie 78.16 3/12/2008 Outperform NS $15.78 +1,947.02% +221.29% +1,725.73 0 Comment
PrincetonAl 91.29 3/7/2008 Outperform 3Y $15.86 +1,936.70% +227.51% +1,709.19 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 72.33 3/24/2008 Outperform 5Y $16.47 +1,861.26% +216.89% +1,644.37 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VRTX.